Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

Healthcare Biotechnology
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

CVR Medical Corp
Bullboard Posts
User Avatar Image
(2)
•••
Comment by Nastroon Mar 17, 2020 7:39am
78 Views
Post# 30816075

RE:RE:RE:RE:Time tonVotevAgain

RE:RE:RE:RE:Time tonVotevAgain

I know what you mean Looney.  The present board are just a bunch of incompetents and shysters.  What do Blunden and Bendick know about running a company for example?  Lynch is just a real estate spiv from Florida and Bakema's landlord and private pilot.  

I don't believe that the exchange will allow their egregious deal to even be put to the shareholders in the first place.  Given the Global IP is worth zero anyway, to ask 12 to 19% if the company for it is a sick joke.  And given that all these clowns are already shareholders of Global, they've just effectively agreed to give themselves a big slice of the company without having to pay for it.  And as for that reptile Bakema, don't get me started.

Even if it gets to a vote as Old Mule says the top 25 shareholders will vote it down anyway.  Can't wait for that they want for the $4m of debts that Global have and want paying for.  We know $200k of that is for Bendick and $2m for Bakema.  Cheque's made payable to their personal accounts please.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities